Establishment Labs Holdings (ESTA) Gains from Investment Securities (2018 - 2020)
Establishment Labs Holdings' (ESTA) quarterly Gains from Investment Securities came in at -$5000.0 in Q3 2020, up 97.56% year-on-year from -$2530.9 in Q4 2019, and down 103.55% quarter-over-quarter from $141000.0 in Q2 2020.
Establishment Labs Holdings (ESTA) Gains from Investment Securities (2018 - 2020) Analysis & Trends
Establishment Labs Holdings' Gains from Investment Securities history runs 3 years deep, the most recent figure standing at -$5000.0 for Q3 2020.
- On a quarterly basis, Gains from Investment Securities rose 97.56% year-over-year to -$5000.0 in Q3 2020; TTM through Jun 2021 was -$5000.0, a 97.65% increase from a year earlier, with the FY2020 full-year figure at -$304000.0, down 10.14% from the prior year.
- Gains from Investment Securities fell to -$5000.0 in Q3 2020 per ESTA's latest filing, from $141000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $694000.0 in Q3 2018 and bottomed at -$440000.0 in Q1 2020.
- The 3-year median for Gains from Investment Securities is $141000.0 (2020), against an average of $104272.7.
- Across the five-year window, Gains from Investment Securities slumped 161.98% in 2019 and jumped 202.92% in 2020, its largest moves.
- Year by year, Gains from Investment Securities stood at $281000.0 in 2018, then advanced by 3.56% to $291000.0 in 2019, then slumped by 101.72% to -$5000.0 in 2020.
- Per Business Quant, the three latest ESTA Gains from Investment Securities figures stand at -$5000.0 (Q3 2020), $141000.0 (Q2 2020), and -$440000.0 (Q1 2020).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Establishment Labs Holdings | 2.75 Bn | 2.68 Bn | 42.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -5,000.00 |
| Sep 30, 2020 | -5,000.00 |
| Jun 30, 2020 | 141,000.00 |
| Jun 30, 2020 | 141,000.00 |
| Mar 31, 2020 | -440,000.00 |
| Mar 31, 2020 | -440,000.00 |
| Dec 31, 2019 | 291,000.00 |
| Dec 31, 2019 | 291,000.00 |
| Sep 30, 2019 | -205,000.00 |
| Sep 30, 2019 | -205,000.00 |
| Jun 30, 2019 | -137,000.00 |
| Jun 30, 2019 | -137,000.00 |
| Mar 31, 2019 | -225,000.00 |
| Mar 31, 2019 | -225,000.00 |
| Dec 31, 2018 | 281,000.00 |
| Dec 31, 2018 | 281,000.00 |
| Sep 30, 2018 | 694,000.00 |
| Sep 30, 2018 | 694,000.00 |
| Jun 30, 2018 | 389,000.00 |
| Jun 30, 2018 | 389,000.00 |